Eyepoint Pharmaceuticals Inc (EYPT) stock news · rev $31.4M
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
This EYPT news page leads with what Eyepoint Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for EYPT yet. We will not pad this page with generic market recap.
Latest reported EYPT revenue for 2025-12-31 was $31.4M. Net income was -$232.0M. Revenue was down 27.5% from 2024-12-31 to 2025-12-31. EYPT currently screens at market cap $1.10B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the EYPT stock page; for the tape open the quote page.
EYPT stock news FAQ
What are EYPT's latest revenue and net income?
Latest cached Eyepoint Pharmaceuticals Inc (EYPT) revenue for Dec 31, 2025 was $31.4M. Net income was -$232.0M. Statements: https://lician.com/financials/eypt
How did EYPT revenue change from the prior cached period?
Cached Eyepoint Pharmaceuticals Inc (EYPT) revenue was down 27.5% from $43.3M (Dec 31, 2024) to $31.4M (Dec 31, 2025). Statements: https://lician.com/financials/eypt
What is EYPT's market cap?
Eyepoint Pharmaceuticals Inc (EYPT) market cap is $1.10B on the latest cached fundamentals snapshot.
What kind of company is EYPT?
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Where is EYPT stock news listed?
Cached stock news for Eyepoint Pharmaceuticals Inc (EYPT) is listed at https://lician.com/news/eypt. Filings: https://lician.com/sec/eypt
Not investment advice.